Invicta Diagnostic share news, announcements and annual reports

NSE: INVICTAHealthcare Services

Invicta Diagnostic Limited · Face value ₹10 · Listed Dec 2025 · Issue price ₹85

₹65.00₹1.50 (2.26%)

Share price at the NSE close on 28 Oct 2026. Previous close ₹66.50.

28 Oct: open ₹65.00, high ₹65.00, low ₹65.00

Range of traded prices from listing on 8 Dec 2025 to 28 Oct 2026

₹58.10Low, 5 Mar 2026₹105.00High, 8 Dec 2025

Market cap: ₹82 Cr
P/E: 16.66
P/B: 1.64
Dividend yield: Nonesince listing in Dec 2025
ROE: 9.8%
ROCE: 12.2%
Debt to equity: 0.07
Volume, NSE: 3,200100.0% delivered

Invicta Diagnostic board meetings

7 filed, newest first.

Sep 2026
- 18 Sep · Board meeting
  Outcome of Board Meeting held on September 18, 2026 wherein Board considered and approved the proposed business outlook and forward-looking guidance to be communicated by the Chairman & Managing Director and Chief Financial Officer to the Members at the Company s 3rd Annual General Meeting scheduled to be held on Saturday, 19th September, 2026.
Aug 2026
- 25 Aug · Board meeting
  Outcome of Board Meeting held on August 25, 2026.
Jul 2026
- 29 Jul · Board meeting
  Outcome of Board Meeting held on July 29, 2026. Board at its meeting held today1. The Board took on record and accepted the resignation of Mr. Rohit Prakash Srivastava (DIN: 01432112) from the office of Whole-time Director (Finance) and Director of the Company2. The Board accepted the resignation of Ms. Konica Rohit Srivastava from the office of Manager of the Company3. The Board appointed Mr. Sanket Vinod Jain (DIN: 08299039) as Managing Director of the Company 4. The Board approved sale/disposal of the Company's entire stake representing 50% partnership interest in MSCRIBEIT INFOTECH LLP, an associate LLP of the Company5. The Board approved Reconstitution of Stakeholders Relationship Committee
- 23 Jul · Board meeting
  1. To consider and take on record the resignation of Mr. Rohit Prakash Srivastava (DIN: 01432112) from the office of Whole-time Director and Director of the Company and to consider waiver of the notice period.2. To consider and take on record the resignation of Ms. Konica Rohit Srivastava from the office of Manager (Key Managerial Personnel) of the Company and to consider waiver of the notice period.3. To consider and approve the appointment of Mr. Sanket Vinod Jain, DIN-08299039 Director of the Company, as the Managing Director of the Company, subject to the approval(s), if any, as may be required under the Companies Act, 2013, the rules made thereunder and other applicable laws4. To consider and approve the sale/disposal of the Company's entire investment representing 50% stake in MSCRIBEIT INFOTECH LLP, an associate LLP of the Company, (which currently holds NIL assets, NIL liabilities, and has no operational business activities) to a non-related party, together with matters incidental thereto.5. To transact such other business as may be considered necessary with the permission of the Chair
May 2026
- 13 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026
Mar 2026
- 25 Mar · Board meeting
  Outcome of Board Meeting held on March 25, 2026
- 21 Mar · Board meeting
  To consider other business matters I. Appointment of Mr. Rohit Prakash Srivastava (DIN: 01432112) as Additional Director (Whole Time Director- Finance) of the Company. II. Approval of Material Related Party Transactions in the ordinary course of business and on arm s length basis, pursuant Section 188 of the Companies Act, 2013, subject to approval of shareholders in ensuing Extra Ordinary General Meeting III. Approval of Related Party Transactions , in the ordinary course of business and on arm s length basis, pursuant Section 188 of the Companies Act, 2013, subject to approval of shareholders in ensuing Extra Ordinary General Meeting IV. Approval for Change, Deviation and Variation in the Objects of Utilisation of the Initial Public Offering ( IPO ) Proceeds and extension of time limit for utilisation of the IPO Proceeds subject to approval of shareholders in ensuing Extra Ordinary General Meeting V. To fix Day, Date, Time of ensuing Extra Ordinary General Meeting

Invicta Diagnostic board meetings

Sep 2026

Aug 2026

Jul 2026

May 2026

Mar 2026